Associations of chemokine receptor polymorphisms with HIV-1 mother-to-child transmission in sub-Saharan Africa: Possible modulation of genetic effects by antiretrovirals

Journal of Acquired Immune Deficiency Syndromes

Volumn 49, Issue 3, 2008, Pages 259-265

  Singh, Kumud K ^a   Hughes, Michael D ^b   Chen, Jie ^b   Phiri, Kelesitse ^b   Rousseau, Christine ^c   Kuhn, Louise ^d   Coutsoudis, Anna ^e   Jackson, J Brooks ^f   Guay, Laura A ^f   Musoke, Philippa ^g   Mmiro, Francis ^g   Semba, Richard D ^f   Spector, Stephen A ^a  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b CENTER FOR BIOSTATISTICS IN AIDS RESEARCH   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

^d Och Spine at New York Presbyterian Hospitals   (United States)

^e UNIVERSITY OF KWAZULU NATAL   (South Africa)

^f JOHNS HOPKINS UNIVERSITY   (United States)

^g MAKERERE UNIVERSITY   (Uganda)

Author keywords

Antiretrovirals; Chemokine chemokine receptor genotypes; HIV 1; Mother to child transmission

Indexed keywords

CHEMOKINE RECEPTOR CCR2; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CX3CR1; NEVIRAPINE; STROMAL CELL DERIVED FACTOR 1; ZIDOVUDINE; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; CCR2 PROTEIN, HUMAN; CHEMOKINE RECEPTOR; CX3CR1 PROTEIN, HUMAN; UNCLASSIFIED DRUG;

ADULT; AFRICA; ALLELE; ANTIVIRAL THERAPY; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG DOSE REDUCTION; DRUG EFFECT; FEMALE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; HEREDITY; HOST; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; IMMUNE RESPONSE; INFANT; MAJOR CLINICAL STUDY; MALE; MOTHER TO CHILD TRANSMISSION; PRIORITY JOURNAL; PROMOTER REGION; RANDOMIZED CONTROLLED TRIAL; REAL TIME POLYMERASE CHAIN REACTION; SINGLE DRUG DOSE; STROMA CELL; VERTICAL TRANSMISSION; VIRUS TRANSMISSION; ACQUIRED IMMUNE DEFICIENCY SYNDROME; DISEASE TRANSMISSION; GENETICS; PREGNANCY;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; ANTI-HIV AGENTS; FEMALE; HIV-1; HUMANS; INFANT; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; MALE; POLYMORPHISM, GENETIC; PREGNANCY; RECEPTORS, CCR2; RECEPTORS, CCR5; RECEPTORS, CHEMOKINE;

EID: 58149168410     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/QAI.0b013e318186eaa4     Document Type: Article

References (31)

1. Omette L, Zanchetta M, Mainardi M, et al. Co-receptor usage of HIV-1 primary isolates, viral burden, and CCR5 genotype in mother-to-child HIV-1 transmission. AIDS. 2000;14:1721-1729.
2. Spencer LT, Ogino MT, Dankner WM, et al. Clinical significance of human immunodeficiency virus type 1 phenotypes in infected children. J Infect Dis. 1994;169:491-495.
3. Behbahani H, Popek E, Garcia P, et al. Up-regulation of CCR5 expression in the placenta is associated with human immunodeficiency virus-1 vertical transmission. Am J Pathol. 2000;157:1811-1818.
4. Ank N, Petersen K, Malmgaard L, et al. Age-dependent role for CCR5 in antiviral host defense against herpes simplex virus type 2. J Virol. 2005; 79:9831-9841.
5. Martinson JJ, Chapman NH, Rees DC, et al. Global distribution of the CCR5 gene 32-basepair deletion. Nat Genet. 1997;16:100-103.
6. Semba RD, Kumwenda N, Hoover DR, et al. Human immunodeficiency virus load in breast milk, mastitis, and mother-to-child transmission of human immunodeficiency virus type 1. J Infect Dis. 1999;180:93-98.
7. Coutsoudis A, Pillay K, Kuhn L, et al, and the South African Vitamin A Study Group. Method of feeding and transmission of HTV-1 from mothers to children by 15 months of age: prospective cohort study from Durban, South Africa. AIDS. 2001;15:379-387.
8. Coutsoudis A, Pillay K, Spooner E, et al. Randomised trial testing effect of vitamin A supplementation on pregnancy outcomes and early motherto-child transmission of HIV-1 in Durban, South Africa. AIDS. 1999;13: 1517-1524.
9. Guay LA, Musoke P, Fleming T, et al. Intrapartum and neonatal singledose nevirapine compared with zidovudine for prevention of motherto-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial. Lancet. 1999;354:795-802.
10. Singh KK, Barroga CF, Hughes MD, et al. Genetic influence of CCR5, CCR2 and SDFI variants on HIV-1 related disease progression and neurological impairment in children with symptomatic HIV-1 infection. J Infect Dis. 2003;188:1461-1472.
11. + lymphocyte count and HIV-1 Rna load. J Infect Dis. 2005;191: 1971-1980.
12. Shieh B, Liau YE, Hsieh PS, et al. Influence of nucleotide polymorphisms in the CCR2 gene and the CCR5 promoter on the expression of cell surface CCR5 and CXCR4. Int Immunol. 2000;12:1311-1318.
13. Shearer WT, Kalish LA, Zimmerman PA. CCR5 HIV-1 vertical transmission. Women and Infants Transmission Study Group. J Acquir Immune Defic Syndr Hum Retrovirol. 1998;17:180-181.
14. Misrahi M, Teglas JP, N'Go N, et al. CCR5 chemokine receptor variant in HIV-1 mother-to-child transmission and disease progression in children. French Pediatric HIV Infection Study Group. JAMA. 1998;279:277-280.
15. Mandl CW, Aberle SW, Henkel JH, et al. Possible influence of the mutant CCR5 allele on vertical transmission of HIV-1. J Med Virol. 1998; 55:51-55.
16. Rousseau CM, Just JJ, Abrams EJ, et al. CCR5del32 in perinatal HIV-1 infection. J Acquir Immune Defic Syndr Hum Retrovirol. 1997;16:239242.
17. Philpott S, Burger H, Charbonneau T, et al. CCR5 genotype and resistance to vertical transmission of HIV-1. J Acquir Immune Defic Syndr. 1999;21: 189-193.
18. Contopoulos-Ioannidis DG, O'Brien TR, Goedert JJ, et al. Effect of CCR5-delta32 heterozygosity on the risk of perinatal HIV-1 infection: a meta-analysis. J Acquir Immune Defic Syndr. 2003;32:70-76.
19. Edelstein RE, Arcuino LA, Hughes JP, et al. Risk of mother-to-infant transmission of HIV-I is not reduced in CCR5/delta32CCR5 heterozygotes. J Acquir Immune Defic Syndr Hum Retrovirol. 1997;16:243-246.
20. Mangano A, Prada F, Roldan A, et al. Distribution of CCR-5 delta32 allele in Argentinian children at risk of HIV-1 infection: its role in vertical transmission. AIDS. 1998;12:109-110.
21. Mangano A, Kopka J, Batalla M, et al. Protective effect of CCR2-64I and not of CCR5-delta32 and SDFl-3' A in pediatric HIV-1 infection. J Acquir Immune Defic Syndr. 2000;23:52-57.
22. Salkowitz JR, Bruse SE, Meyerson H, et al. CCR5 promoter polymorphism determines macrophage CCR5 density and magnitude of HIV-1 propagation in vitro. Clin Immunol. 2003;108:234-240.
23. Schramm DB, Kuhn L, Gray GE, et al. In vivo effects of HIV-1 exposure in the presence and absence of single-dose nevirapine on cellular plasma activation markers of infants born to HIV-1 -seropositive mothers. J Acquir Immune Defic Syndr. 2006;42:545-553.
24. Kuhn L, Schramm DB, Donninger S, et al. African infants' CCL3 gene copies influence perinatal HIV transmission in the absence of maternal nevirapine. AIDS. 2007;21:1753-1761.
25. Pedersen BR, Kamwendo D, Blood M, et al. CCR5 haplotypes and mother-to-child HIV transmission in Malawi. PLOS ONE. 2007;2:e838.
26. Kostrikis LG, Neumann AU, Thomson B, et al. A polymorphism in the regulatory region of the CC-chemokine receptor 5 gene influences perinatal transmission of human immunodeficiency virus type 1 to African-American infants. J Virol. 1999;73:10264-10271.
27. John GC, Bird T, Overbaugh J, et al. CCR5 promoter polymorphisms in a Kenyan perinatal human immunodeficiency virus type 1 cohort: association with increased 2-year maternal mortality. J Infect Dis. 2001; 184:89-92.
28. 3CR1. Science. 2000;287:2274-2277.
29. Teglas JP, N'Go N, Burgard M, et al. CCR2B-64I chemokine receptor allele and mother-to-child HIV-1 transmission or disease progression in children. French Pediatric HIV Infection Study Group. J Acquir Immune Defic Syndr. 1999;22:267-271.
30. Brouwer KC, Yang C, Parekh S, et al. Effect of CCR2 chemokine receptor polymorphism on HIV type 1 mother-to-child transmission and child survival in Western Kenya. AIDS Res Hum Retroviruses. 2005;21:358362.
31. John GC, Rousseau C, Dong T, et al. Materna1 SDFl 3' A polymorphism is associated with increased perinatal human immunodeficiency virus type 1 transmission. J Virol. 2000;74:5736-5739.